<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01817036</url>
  </required_header>
  <id_info>
    <org_study_id>KSCX2-EW-R-10-VD</org_study_id>
    <nct_id>NCT01817036</nct_id>
  </id_info>
  <brief_title>Vitamin D Intervention Trial in Healthy Chinese</brief_title>
  <official_title>Knowledge Innovation Project of CAS - Genetic and Nutritional Association Studies on Metabolism-related Diseases in Chinese Population -- Vitamin D Intervention Study：A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Academy of Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese Academy of Sciences</source>
  <brief_summary>
    <textblock>
      To determine the dose-response between the doses of vitamin D3 supplements and raised serum
      levels of 25(OH)D and also the dose of vitamin D3 required to achieve circulating 25(OH)D ≥
      75 nmol/L;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recent epidemiological studies suggested that serum 25-hydroxyvitamin D [25(OH)D]
      concentration ≥75 nmol/L appeared to be optimal for preventing cardiometabolic diseases and
      improving bone health. To achieve this goal, a daily intake of 1000 IU or equivalent amount
      from other sources, is needed, which is twice as much as the RDA recommended by Chinese
      Nutrition Society. Meanwhile,epidemiological evidences show that large proportions of Chinese
      may suffer vitamin D insufficiency or deficiency whereas the current RDA in China might be
      too low to provide adequate vitamin D for people's health.

      In order to fill up this gap, therefore, it is essential to determine the dose-response
      between the doses of vitamin D3 supplements and raised serum levels of 25(OH)D and also the
      dose of vitamin D3 required to achieve circulating 25(OH)D ≥ 75 nmol/L.Ultimately, the
      current study will provide important evidence for establishing optimal vitamin D requirement
      for Chinese people
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>25-hydroxyvitamin D</measure>
    <time_frame>16 weeks</time_frame>
    <description>Serum 25(OH)D concentration will be assayed by utilizing a liquid chromatography-mass spectrometry (LC-MS) method</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>alanine aminotransferase（ALT)</measure>
    <time_frame>16 weeks</time_frame>
    <description>Serum ALT will be measured by an Automatic biochemical analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>aspartate aminotransferase(AST)</measure>
    <time_frame>16 weeks</time_frame>
    <description>Serum AST will be measured by an Automatic biochemical analyzer;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>glutamyl transpeptidase（GGT）</measure>
    <time_frame>16 weeks</time_frame>
    <description>Serum GGT will be measured by an Automatic biochemical analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>creatinine</measure>
    <time_frame>16 weeks</time_frame>
    <description>creatinine will be measured by an Automatic biochemical analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>uric acid</measure>
    <time_frame>16 weeks</time_frame>
    <description>Serum uric acid will be measured by an Automatic biochemical analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urea nitrogen</measure>
    <time_frame>16 weeks</time_frame>
    <description>Serum urea nitrogen will be measured by an Automatic biochemical analyzer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>calcium</measure>
    <time_frame>16 weeks</time_frame>
    <description>Serum calcium will be measured by an Automatic biochemical analyzer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>phosphate</measure>
    <time_frame>16 weeks</time_frame>
    <description>Serum phosphate will be measured by an Automatic biochemical analyzer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>parathyroid hormone（PTH）</measure>
    <time_frame>16 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>5 placebo pills per day, 16 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>400 IU</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(4 placebo pills + 1 vitamin D pill) per day, 16 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>800 IU</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(3 placebo pills + 2 vitamin D pills) per day, 16 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1200 IU</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>(2 placebo pills + 3 vitamin D pills) per day, 16 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2000 IU</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 vitamin D pills per day, 16 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>placebo</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>400 IU</arm_group_label>
    <arm_group_label>800 IU</arm_group_label>
    <arm_group_label>1200 IU</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <description>400 IU vitamin D per pill</description>
    <arm_group_label>400 IU</arm_group_label>
    <arm_group_label>800 IU</arm_group_label>
    <arm_group_label>1200 IU</arm_group_label>
    <arm_group_label>2000 IU</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: 20-45 years. with vitamin D deficiency (25(OH)D &lt; 50 nmol/l)

        Exclusion Criteria:

          -  BMI &lt; 18.5 kg/m2, or BMI ≥ 25 kg/m2

          -  Total intake of calcium from diet or supplements &gt;1200mg/d, or fasting serum calcium
             level ≥2.75 mmol/l

          -  Participating in other clinical studies within previous 3 months

          -  Taking vitamin D supplements within previous 3 months

          -  Using medications that may affect vitamin D metabolism in previous 3 months;

          -  Concomitant with clinical conditions, like liver dysfunction (serum alanine
             transaminase (ALT) ≥40 U/L; and/or aspartate transaminase (AST) ≥40 U/L; Glutamyl
             transpeptidase （GGT）≥50 U/L; serum creatinine &lt; 50 or &gt; 120 µmol/L; urea nitrogen (UN)
             &lt; 7 or &gt; 18 mg/dl, and/or urine acid &lt;90 or &gt;420 µmol/L; which may affect vitamin D
             metabolism;

          -  History of drug or alcohol abuse (&gt;40 g/d)

          -  Women during pregnancy or lactation

          -  Individuals with mental disorders or current use of antidepressants, the conditions
             which may affect him or her understanding and unwillingness to the intervention;

          -  Having clinically diagnosed AIDS, hepatitis A, hepatitis B, tuberculosis and other
             infectious diseases.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xu Lin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Nutritional Sciecnes, Chinese Acadamy of Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute for Nutritional Sciences, Chinese Academy of Sciences</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200031</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 20, 2013</study_first_submitted>
  <study_first_submitted_qc>March 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2013</study_first_posted>
  <last_update_submitted>January 15, 2016</last_update_submitted>
  <last_update_submitted_qc>January 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 18, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese Academy of Sciences</investigator_affiliation>
    <investigator_full_name>Xu Lin</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>vitamin D</keyword>
  <keyword>deficiency</keyword>
  <keyword>dose response</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

